Gamble Jones Investment Counsel / ABT
Gamble Jones Investment Counsel’s Abbott Laboratories Position
Does Gamble Jones Investment Counsel own Abbott Laboratories (ABT)? Yes — 218.6K shares worth $24M (+1.81% of its 13F portfolio) as of Q4 2022, down from 219.7K shares the prior filed quarter.
Position Value
$24M
Q4 2022
Shares
218.6K
% of Portfolio
+1.81%
Quarters Held
17
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2022 | 218.6K | $24M | +1.81% |
| Q3 2022 | 219.7K | $21M | +1.73% |
| Q2 2022 | 223.2K | $24M | +1.79% |
| Q1 2022 | 231.3K | $27M | +1.71% |
| Q4 2021 | 232.1K | $33M | +1.93% |
| Q3 2021 | 232.7K | $27M | +1.80% |
| Q2 2021 | 234.0K | $27M | +1.76% |
| Q1 2021 | 235.2K | $28M | +1.90% |
| Q4 2020 | 235.3K | $26M | +1.76% |
| Q3 2020 | 259.3K | $28M | +2.05% |
| Q2 2020 | 262.2K | $24M | +1.92% |
| Q1 2020 | 262.1K | $21M | +1.91% |
| Q4 2019 | 257.8K | $22M | +1.75% |
| Q3 2019 | 255.3K | $21M | +1.76% |
| Q2 2019 | 257.4K | $22M | +1.85% |
| Q1 2019 | 265.6K | $21M | +1.88% |
| Q4 2018 | 266.0K | $19M | +1.93% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gamble Jones Investment Counsel’s full portfolio or all institutional holders of ABT.